Cerebrolysin

Product information

Cerebrolysin is a complex mixture of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins via standardized enzymatic proteolysis. Manufactured by EVER Neuro Pharma (Austria), it is the most clinically studied neurotrophic peptide preparation in the world, with over 200 clinical trials across stroke recovery, traumatic brain injury, Alzheimer's disease, and cognitive enhancement.

Cerebrolysin's mechanism mirrors endogenous neurotrophic factors (BDNF, GDNF, NGF, CNTF), supporting neuronal survival, synaptic plasticity, neurogenesis, and neuroprotection. Unlike single-peptide nootropics, Cerebrolysin delivers a multi-factor neurotrophic cocktail that activates multiple neuroprotective pathways simultaneously.

Approved as a prescription medication in 40+ countries for neurological conditions. Not FDA-approved in the United States. Available through prescriber authorization and international pharmacy sourcing.

Benefits

• Multi-factor neurotrophic support
• Neurogenesis and synaptic plasticity
• Neuroprotection (BDNF, NGF, GDNF mimetic)
• 200+ clinical trials worldwide
• Stroke and TBI recovery support
• Cognitive enhancement and memory consolidation

Specifications

Fill / pack

5mL ampule (5-pack)

Format

Injectable

Serving

5-10mL per session

Servings per container

5 ampules per pack

Listed purity

Standardized biological extract

Molecular weight / composition

~10,000 Da avg (peptide fraction)

Storage

Store below 25°C, protect from light